Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03012321
Brief Title: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

First Submitted : January 3, 2017
First Submitted that Met QC Criteria : January 4, 2017
First Posted : January 6, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : April 24, 2019
Last Update Posted : April 25, 2019